By Josh White
Date: Wednesday 15 Oct 2025
(Sharecast News) - Ixico announced two new agreements worth a combined £1.2m on Wednesday, including a contract to support the validation of a diagnostic blood test and an extension to an existing Alzheimer's disease clinical trial.
By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - Ixico has secured two new clinical trial contracts in neurological disorders with a combined value of about £1.3m, it announced on Friday, extending its presence in both Alzheimer's disease and rare central nervous system conditions.
By Josh White
Date: Thursday 17 Jul 2025
(Sharecast News) - Ixico said in an update on Thursday that it expects revenue for the financial year ending 30 September to be at least £6.3m, ahead of market expectations and representing a 9% increase from the prior year.
| Currency | UK Pounds |
| Share Price | 10.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 14.00p |
| 52 Week Low | 7.75p |
| Volume | 210 |
| Shares Issued | 92.67m |
| Market Cap | £9.96m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
You are here: research